Authors:
TOBINAI K
KOBAYASHI Y
NARABAYASHI M
OGURA M
KAGAMI Y
MORISHIMA Y
OHTSU T
IGARASHI T
SASAKI Y
KINOSHITA T
MURATE T
Citation: K. Tobinai et al., FEASIBILITY AND PHARMACOKINETIC STUDY OF A CHIMERIC ANTI-CD20 MONOCLONAL-ANTIBODY (IDEC-C2B8, RITUXIMAB) IN RELAPSED B-CELL LYMPHOMA, Annals of oncology, 9(5), 1998, pp. 527-534
Authors:
OHTSU T
SASAKI Y
IGARASHI T
MURAYAMA T
KOBAYASHI Y
TOBINAI K
Citation: T. Ohtsu et al., UNEXPECTED HEPATOTOXICITIES IN PATIENTS WITH NON-HODGKINS-LYMPHOMA TREATED WITH IRINOTECAN (CPT-11) AND ETOPOSIDE, Japanese Journal of Clinical Oncology, 28(8), 1998, pp. 502-506
Authors:
TOGITANI K
TAKEYAMA K
YOKOZAWA T
ANDOH M
NARABAYASHI M
KOBAYASHI Y
TAKENAKA T
TOBINAI K
Citation: K. Togitani et al., THROMBOTIC MICROANGIOPATHY OF HYPERACUTE ONSET AFTER AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN MALIGNANT-LYMPHOMA, Bone marrow transplantation, 21(12), 1998, pp. 1263-1266
Authors:
NAKATA M
MATSUNO Y
TAKENAKA T
KOBAYASHI Y
TAKEYAMA K
YOKOZAWA T
TOBINAI K
Citation: M. Nakata et al., B-CELL LYMPHOMA ACCOMPANYING MONOCLONAL MACROGLOBULINEMIA WITH FEATURES SUGGESTING MARGINAL ZONE B-CELL LYMPHOMA, International journal of hematology, 65(4), 1997, pp. 405-411
Authors:
TOBINAI K
OGURA M
HOTTA T
KOBAYASHI Y
NARABAYASHI M
SUZUKI R
KINOSHITA T
KOZURU M
UIKE N
OHASHI Y
Citation: K. Tobinai et al., PHASE-I STUDY OF CLADRIBINE (2-CHLORODEOXYADENOSINE) IN LYMPHOID MALIGNANCIES, Japanese Journal of Clinical Oncology, 27(3), 1997, pp. 146-153
Authors:
OGURA M
MORISHIMA Y
KOBAYASHI Y
SASAKI Y
OHTSU T
MURATE T
KINOSHITA T
TOBINAI K
Citation: M. Ogura et al., PHASE-I STUDY OF DEC-C2B8 [RITUXIMAB] IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL [CD20-HODGKINS-LYMPHOMA IN JAPAN(] NON), Experimental hematology, 25(8), 1997, pp. 407-407
Authors:
KOBAYASHI Y
ONO H
SAITO D
NARABAYASHI M
TAKENAKA T
TOBINAI K
Citation: Y. Kobayashi et al., TRISOMY-3 IN GASTRIC LOW-GRADE MALT-ANALYSIS BY IN-SITU HYBRIDIZATIONON TOUCH SMEAR SAMPLES, Blood, 90(10), 1997, pp. 3574-3574
Authors:
KATSUMATA N
MATSUNO Y
NAKAYAMA H
TAKENAKA T
KOBAYASHI Y
TAKEYAMA K
NARABAYASHI M
FUKUSHIMA T
YOKOZAWA T
NAKATA M
TAJIMA K
IKEDA H
TOBINAI K
Citation: N. Katsumata et al., PROGNOSTIC FACTORS AND A PREDICTIVE MODEL OF FOLLICULAR LYMPHOMA - A 25-YEAR STUDY AT A SINGLE INSTITUTION IN JAPAN, Japanese Journal of Clinical Oncology, 26(6), 1996, pp. 445-454
Authors:
TOBINAI K
HOTTA T
SAITO H
OHNISHI K
OHNO R
OGURA M
ARIYOSHI Y
TAKEYAMA K
KOBAYASHI T
OHASHI Y
SHIRAKAWA S
Citation: K. Tobinai et al., COMBINATION PHASE I II STUDY OF IRINOTECAN HYDROCHLORIDE (CPT-11) ANDCARBOPLATIN IN RELAPSED OR REFRACTORY NON-HODGKINS-LYMPHOMA/, Japanese Journal of Clinical Oncology, 26(6), 1996, pp. 455-460
Authors:
KOHNO A
TAKEYAMA K
NARABAYASHI M
OKAMOTO R
ADACHI I
TOBINAI K
SHIMOYAMA M
Citation: A. Kohno et al., LOW-DOSE GRANULOCYTE-COLONY-STIMULATING FACTOR ENABLES THE EFFICIENT COLLECTION OF PERIPHERAL-BLOOD STEM-CELLS AFTER DISEASE-ORIENTED, CONVENTIONAL-DOSE CHEMOTHERAPY FOR BREAST-CANCER, MALIGNANT-LYMPHOMA AND GERM-CELL TUMOR, Bone marrow transplantation, 15(1), 1995, pp. 49-54
Citation: K. Tobinai et al., INTERFERON-ALFA AND ZIDOVUDINE IN ADULT T-CELL LEUKEMIA-LYMPHOMA, The New England journal of medicine, 333(19), 1995, pp. 1285-1285
Authors:
SHIMOYAMA M
OYAMA A
TAJIMA K
TOBINAI K
MINATO K
TAKENAKA T
KONDA C
TAKEYAMA K
KOHNO A
NARABAYASHI M
TAMAYOSE K
SUZUKI H
KURITA S
OHTA K
MUKAI K
WATANABE S
SUCHI T
Citation: M. Shimoyama et al., DIFFERENCES IN CLINICOPATHOLOGICAL CHARACTERISTICS AND MAJOR PROGNOSTIC FACTORS BETWEEN B-LYMPHOMA AND PERIPHERAL T-LYMPHOMA EXCLUDING ADULT T-CELL LEUKEMIA-LYMPHOMA, Leukemia & lymphoma, 10(4-5), 1993, pp. 335-342
Authors:
KAGAMI Y
TOBINAI K
KINOSHITA T
NAGAI H
HOTTA T
SETO M
UEDA R
SAITO H
Citation: Y. Kagami et al., NOVEL INTERLEUKIN-2 DEPENDENT T-CELL LINE DERIVED FROM ADULT T-CELL LEUKEMIA NOT ASSOCIATED WITH HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I, Japanese journal of cancer research, 84(4), 1993, pp. 371-378
Authors:
TOBINAI K
KOHNO A
SHIMADA Y
WATANABE T
TAMURA T
TAKEYAMA K
NARABAYASHI M
FUKUTOMI T
KONDO H
SHIMOYAMA M
SUEMASU K
Citation: K. Tobinai et al., TOXICITY GRADING CRITERIA OF THE JAPAN CLINICAL ONCOLOGY GROUP, Japanese Journal of Clinical Oncology, 23(4), 1993, pp. 250-257